Biological function of dipeptidyl peptidase-4 on type 2 diabetes patients and diabetic mice

Current Research in Translational Medicine ◽

10.1016/j.retram.2018.12.002 ◽

2019 ◽

Vol 67 (3) ◽

pp. 89-92 ◽

Author(s):

Jing Qiao ◽

Lei Li ◽

Yanchun Ma ◽

Ruhui Shi ◽

Mei Teng

Keyword(s):

Type 2 Diabetes ◽

Biological Function ◽

Dipeptidyl Peptidase ◽

Diabetic Mice ◽

Dipeptidyl Peptidase 4 ◽

Diabetes Patients

Download Full-text

Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase‐4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2058 ◽

2020 ◽

Author(s):

Chen‐Yi Yang ◽

Wei‐Ann Lin ◽

Pei‐Fang Su ◽

Lun‐Jie Li ◽

Chun‐Ting Yang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Diseases ◽

Treatment Effects ◽

Dipeptidyl Peptidase ◽

Heterogeneous Treatment Effects ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Review for "Lower Cardiorenal Risk with Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study"

10.1111/dom.14189/v2/review4 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Dipeptidyl Peptidase ◽

Renal Diseases ◽

Dipeptidyl Peptidase 4 ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Decision letter for "Lower Cardiorenal Risk with Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study"

10.1111/dom.14189/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Dipeptidyl Peptidase ◽

Renal Diseases ◽

Dipeptidyl Peptidase 4 ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Comparative studies of dipeptidyl peptidase 4 inhibitor vs sulphonylurea among Muslim Type 2 diabetes patients who fast in the month of Ramadan: A systematic review and meta-analysis

Primary Care Diabetes ◽

10.1016/j.pcd.2015.09.001 ◽

2016 ◽

Vol 10 (3) ◽

pp. 210-219 ◽

Author(s):

Huai Heng Loh ◽

Anne Yee ◽

Huai Seng Loh ◽

Norlela Sukor ◽

Nor Azmi Kamaruddin

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Comparative Studies ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Diabetes Patients

Download Full-text

Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A Narrative Review

Indian Journal of Public Health Research & Development ◽

10.37506/ijphrd.v11i7.10232 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Economic Burden ◽

Dipeptidyl Peptidase ◽

Narrative Review ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Diabetes Patients

Download Full-text

Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients

Frontiers in Endocrinology ◽

10.3389/fendo.2019.00505 ◽

2019 ◽

Vol 10 ◽

Author(s):

Jit Sarkar ◽

Titli Nargis ◽

Om Tantia ◽

Sujoy Ghosh ◽

Partha Chakrabarti

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Independent Parameter ◽

Dipeptidyl Peptidase 4 ◽

Diabetes Patients

Download Full-text

Decision letter for "Lower Cardiorenal Risk with Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study"

10.1111/dom.14189/v1/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Dipeptidyl Peptidase ◽

Renal Diseases ◽

Dipeptidyl Peptidase 4 ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Review for "Lower Cardiorenal Risk with Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study"

10.1111/dom.14189/v1/review4 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Dipeptidyl Peptidase ◽

Renal Diseases ◽

Dipeptidyl Peptidase 4 ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text

Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan

Journal of Diabetes Investigation ◽

10.1111/jdi.12474 ◽

2016 ◽

Vol 7 (5) ◽

pp. 737-743 ◽

Author(s):

Karen Kurtyka ◽

Rie Nishikino ◽

Chie Ito ◽

Kim Brodovicz ◽

Yong Chen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Health Insurance ◽

Dipeptidyl Peptidase ◽

Inhibitor Therapy ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Diabetes Patients

Download Full-text

Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease

Journal of Diabetes Investigation ◽

10.1111/jdi.12917 ◽

2018 ◽

Vol 10 (3) ◽

pp. 706-713 ◽

Author(s):

Munehiro Kitada ◽

Yoshio Ogura ◽

Kyoko Nitta ◽

Mizue Fujii ◽

Keizo Kanasaki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Kidney Disease ◽

Glucose Control ◽

Diabetic Kidney Disease ◽

Dipeptidyl Peptidase ◽

Diabetic Kidney ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Diabetes Patients

Download Full-text